What the company does
Mabpharm Limited, a biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People's Republic of China. It offers CMAB007, a recombinant humanized anti-immunoglobulin E monoclonal antibody for treatment of asthma patients; CMAB009, a recombinant anti-EGFR chimeric monoclonal antibody for the first-line treatment of metastatic colorectal cancer; and CMAB008, a recombinant anti-TNF-alpha chimeric monoclonal antibody for the treatment of ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, Crohn's disease in adults and pediatric patients aged above 6 years old, fistula Crohn's disease, and psoriasis. The …
What the weekly tape is saying
2181 closed the latest completed week at 0.39 HKD. The 4-week return is -24.5% and the 12-week return is -26.0%. Trend Signal is inactive, Market Dynamics is -0.74. Setup signature: Risk-first tape with a 9/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.50 HKD
- Vs Trend Line
- -22.5%
- Fair Value
- 0.47 HKD
- Vs Fair Value
- -17.9%
- 52W High
- 0.88 HKD
- 52W Low
- 0.31 HKD
- Drawdown
- -56.2%
- Range Position
- 13.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 20
- 52W Active Breadth
- 38.5%
- Sector Scope
- HK Healthcare
- Sector Rank
- 174 of 257
- Sector Percentile
- 32.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 57 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.74
- 4W MD Change
- -83.6%
- Relative Strength
- -27.00
- 4W RS Change
- -187.1%
- Expectation
- Negative
- Probability
- 38.96%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 316.0K
- 13W Average
- 6.0M
- 52W Average
- 2.8M
- Vs 13W
- 0.1x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.0%
- 52W Volatility
- 12.8%
- Upside Weeks
- 21
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 9.3% / -7.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 1.6B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.39 HKD | -3.8% | 0.50 HKD | 0.47 HKD | -0.74 | -27.00 | 316.0K | Off |
| 5 Jun 2026 | 0.40 HKD | 1.3% | 0.50 HKD | 0.47 HKD | -0.49 | -25.24 | 11.7M | Off |
| 29 May 2026 | 0.40 HKD | -10.2% | 0.51 HKD | 0.47 HKD | -0.48 | -27.11 | 320.0K | Off |
| 22 May 2026 | 0.44 HKD | -13.7% | 0.51 HKD | 0.47 HKD | -0.40 | -20.56 | 1.0M | Off |
| 15 May 2026 | 0.51 HKD | 9.7% | 0.51 HKD | 0.47 HKD | -0.40 | -9.40 | 528.0K | Off |
| 8 May 2026 | 0.47 HKD | 4.5% | 0.52 HKD | 0.47 HKD | -0.49 | -18.67 | 702.0K | Off |
| 1 May 2026 | 0.45 HKD | 0.0% | 0.53 HKD | 0.47 HKD | -0.36 | -20.42 | 482.0K | Off |
| 24 Apr 2026 | 0.45 HKD | -2.2% | 0.53 HKD | 0.47 HKD | -0.20 | -21.17 | 526.0K | Off |
| 17 Apr 2026 | 0.46 HKD | -2.2% | 0.54 HKD | 0.47 HKD | 0.14 | -20.23 | 1.9M | Off |
| 10 Apr 2026 | 0.47 HKD | -7.0% | 0.55 HKD | 0.47 HKD | 0.40 | -18.05 | 8.3M | Off |
| 3 Apr 2026 | 0.50 HKD | -9.1% | 0.56 HKD | 0.48 HKD | 0.65 | -9.59 | 2.2M | Off |
| 27 Mar 2026 | 0.55 HKD | 5.8% | 0.57 HKD | 0.48 HKD | 0.43 | -0.18 | 23.3M | Off |
| 20 Mar 2026 | 0.52 HKD | -25.7% | 0.58 HKD | 0.48 HKD | 0.06 | -7.26 | 26.5M | Off |
| 13 Mar 2026 | 0.70 HKD | 70.7% | 0.59 HKD | 0.48 HKD | -0.15 | 23.95 | 18.5M | Off |